Functional Assessment and Pulmonary Rehabilitation: Challenges and Perspectives for Comprehensive Care
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorUniversidade do Estado do Pará
About this trial
Individuals with Chronic Obstructive Pulmonary Disease (COPD) present with respiratory muscle dysfunction, characterized by reduced diaphragmatic contractility and mobility due to pulmonary hyperinflation, oxidative stress, and systemic inflammation. Effective assessment of diaphragmatic function is crucial for monitoring progress in pulmonary rehabilitation programs. This study aims to evaluate diaphragmatic function and mobility in COPD patients undergoing pulmonary rehabilitation with inspiratory muscle training, using ultrasound, and to identify associations between diaphragmatic dysfunction and clinical symptoms such as dyspnea and fatigue. A randomized clinical trial will be conducted to investigate the impact of rehabilitation on diaphragmatic function, correlating it with pulmonary function and physical performance.
Eligibility criteria
Qualifiers
Age 40 years or older.
Both sexes are eligible (men and women).
Clinically diagnosed COPD, clinically stable, classified in Stages I, II, III or IV of GOLD (Global Initiative for Chronic Obstructive Lung Disease).
Ability to understand and provide the signed Informed Consent Form to participate in the study.
Disqualifiers
Physical limitations and/or cognitive impairment that prevent the execution of the study protocol.
Currently engaged in physical therapy treatment and/or physical activity that may interfere with the study results.
Presence of severe, uncontrolled, or disabling comorbidities.
Trial design
Treatments tested in this trial
- Pulmonary rehabilitation combined with inspiratory muscle training
- Pulmonary rehabilitation with placebo inspiratory muscle training
Treatment groups
46 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov